CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/22/2023ACC: 0001209191-23-011926
DirectorOfficer· President & CEO
Since Aug 2018
+1.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.50K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+1.50K
Price / share
—
Trade value
—
% of position
54.8%
2/17/2023
2.73K→4.24K
Total
Net shares
+1.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 2/17/2023 | A · Award | +1.50K | — | — | 54.8% | 2.73K | 4.24K |
| Total | +1.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported